• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆组织多肽抗原测定在膀胱尿路上皮癌诊断及随访中的意义

Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancer.

作者信息

Adolphs H D, Oehr P

出版信息

Urol Res. 1984;12(2):125-8. doi: 10.1007/BF00257178.

DOI:10.1007/BF00257178
PMID:6740835
Abstract

Plasma concentrations of tissue polypeptide antigen (TPA) were determined in 104 patients with all stages and grades of urinary bladder cancer. Patients with evidence of bacterial or virus infections were excluded. In addition, follow-up controls after treatment were performed. At a rate of 5% false positive values, the diagnostic sensitivity for the tumour stage pTis/pT1 was 63% and for the stages pT2-4 it was 76%. Patients with proved lymph node or distant metastases showed elevated values in 100% of cases. A positive correlation was found between the 3 grades of malignancy and the TPA concentrations. Except for the tumour diagnosis, TPA is a valuable parameter for follow-up controls. Our results show a very good correlation of the plasma TPA concentration with tumour progression as well as with stabilisation and regression after treatment.

摘要

对104例处于各阶段和分级的膀胱癌患者测定了血浆组织多肽抗原(TPA)浓度。排除有细菌或病毒感染迹象的患者。此外,还进行了治疗后的随访对照。在假阳性率为5%的情况下,肿瘤分期为pTis/pT1时诊断敏感性为63%,pT2 - 4期时为76%。经证实有淋巴结或远处转移的患者100%显示TPA值升高。在恶性肿瘤的3个分级与TPA浓度之间发现了正相关。除肿瘤诊断外,TPA是随访对照的一个有价值的参数。我们的结果显示血浆TPA浓度与肿瘤进展以及治疗后的稳定和消退有很好的相关性。

相似文献

1
Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancer.血浆组织多肽抗原测定在膀胱尿路上皮癌诊断及随访中的意义
Urol Res. 1984;12(2):125-8. doi: 10.1007/BF00257178.
2
Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
Oncology. 1987;44(2):118-23. doi: 10.1159/000226458.
3
Tissue polypeptide antigen (TPA) in urinary bladder cancer cytology: a follow-up study.膀胱癌细胞学中的组织多肽抗原(TPA):一项随访研究。
Oncology. 1990;47(1):37-42. doi: 10.1159/000226782.
4
[Immunohistochemical study of tissue polypeptide antigen (TPA) in human urinary bladder tumors].[人膀胱肿瘤组织多肽抗原(TPA)的免疫组织化学研究]
Nihon Hinyokika Gakkai Zasshi. 1989 Oct;80(10):1430-5. doi: 10.5980/jpnjurol1989.80.1430.
5
Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma.尿组织多肽抗原(TPA)、流式细胞术及细胞学作为膀胱癌肿瘤侵袭性标志物的研究
Urol Res. 1989;17(5):269-72. doi: 10.1007/BF00262980.
6
[Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma].[膀胱癌患者组织多肽抗原的血液及尿液测定]
Minerva Urol Nefrol. 1990 Apr-Jun;42(2):69-71.
7
Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract.评估组织多肽抗原血清水平以监测尿路移行癌患者化疗期间的疾病活动情况。
J Cancer Res Clin Oncol. 1992;118(8):626-8. doi: 10.1007/BF01211809.
8
Serum TPS versus TPA in Egyptian bladder cancer patients.埃及膀胱癌患者血清组织多肽特异性抗原与组织多肽抗原的比较
Int J Biol Markers. 1993 Oct-Dec;8(4):221-6. doi: 10.1177/172460089300800404.
9
Usefulness of tissue polypeptide antigen in the follow-up of bladder cancer.组织多肽抗原在膀胱癌随访中的应用价值
Urology. 2003 Aug;62(2):243-8. doi: 10.1016/s0090-4295(03)00263-2.
10
[Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].膀胱移行癌中抗原19-9(CA 19-9)的免疫组织化学测定
Minerva Urol Nefrol. 1992 Jul-Sep;44(3):169-72.

引用本文的文献

1
History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.肺癌中传统血清生物标志物的历史、分子特征及临床重要性
Surg Today. 2017 Sep;47(9):1037-1059. doi: 10.1007/s00595-017-1477-y. Epub 2017 Feb 22.
2
Simultaneous determination of six tumor markers in patients with prostatic carcinoma and bladder tumors.同时测定前列腺癌和膀胱肿瘤患者的六种肿瘤标志物。
Urol Res. 1985;13(3):133-6. doi: 10.1007/BF00256074.
3
Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma.

本文引用的文献

1
Immuno-histochemical localization of tissue polypeptide antigen (TPA) and carcino-embryonic antigen (CEA) in breast cancer. A comparative study.乳腺癌组织中组织多肽抗原(TPA)和癌胚抗原(CEA)的免疫组织化学定位:一项对比研究
Acta Pathol Microbiol Immunol Scand A. 1982 Nov;90(6):471-6. doi: 10.1111/j.1699-0463.1982.tb00124_90a.x.
2
A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.对癌症或良性肿瘤患者血清或尿液(或两者)中的组织多肽抗原进行初步评估。
Clin Chem. 1978 Jun;24(6):868-72.
3
Frequent elevation of tissue polypeptide antigen in the sera of workers exposed to bladder carcinogens.
尿组织多肽抗原(TPA)、流式细胞术及细胞学作为膀胱癌肿瘤侵袭性标志物的研究
Urol Res. 1989;17(5):269-72. doi: 10.1007/BF00262980.
4
Tissue polypeptide antigen (TPA), some cytokeratins and epithelial membrane antigen (EMA) in normal, inflamed and malignant urothelium.
Urol Res. 1987;15(4):191-4. doi: 10.1007/BF00262097.
5
Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract.评估组织多肽抗原血清水平以监测尿路移行癌患者化疗期间的疾病活动情况。
J Cancer Res Clin Oncol. 1992;118(8):626-8. doi: 10.1007/BF01211809.
Int J Cancer. 1978 Nov 15;22(5):542-5. doi: 10.1002/ijc.2910220506.